Disappearance of the angiogenic potential of endothelial cells caused by Argonaute2 knockdown

Biochemical and Biophysical Research Communications

Volumn 368, Issue 2, 2008, Pages 243-248

  Asai, Tomohiro ^a   Suzuki, Yuko ^a   Matsushita, Saori ^a   Yonezawa, Sei ^a   Yokota, Junichi ^a   Katanasaka, Yasufumi ^a   Ishida, Tatsuhiro ^b   Dewa, Takehisa ^c   Kiwada, Hiroshi ^b   Nango, Mamoru ^c   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Angiogenesis; Argonaute2; Polycation liposomes; siRNA

Indexed keywords

ARGONAUTE 2 PROTEIN; LIPOSOME; POLYCATION; SMALL INTERFERING RNA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ASSAY; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL;

APOPTOSIS; CELL LINE; CELL PROLIFERATION; ENDOTHELIAL CELLS; EUKARYOTIC INITIATION FACTOR-2; GENE SILENCING; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 39549098683     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.074     Document Type: Article

References (17)

1. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
2. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
3. Pai S.I., Lin Y.Y., Macaes B., Meneshian A., Hung C.F., and Wu T.C. Prospects of RNA interference therapy for cancer. Gene Ther. 13 (2006) 464-477
4. Gregory R.I., Chendrimada T.P., Cooch N., and Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123 (2005) 631-640
5. Okamura K., Ishizuka A., Siomi H., and Siomi M.C. Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways. Genes Dev. 18 (2004) 1655-1666
6. Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.J., Hammond S.M., Joshua-Tor L., and Hannon G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305 (2004) 1437-1441
7. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., and Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15 (2004) 185-197
8. Matranga C., Tomari Y., Shin C., Bartel D.P., and Zamore P.D. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123 (2005) 607-620
9. Cristofanilli M., Charnsangavej C., and Hortobagyi G.N. Angiogenesis modulation in cancer research: novel clinical approaches. Nat. Rev. Drug Discov. 1 (2002) 415-426
10. Shimizu K., Asai T., and Oku N. Antineovascular therapy, a novel antiangiogenic approach. Expert Opin. Ther. Targets 9 (2005) 63-76
11. Ferrara N., Hillan K.J., and Novotny W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem. Biophys. Res. Commun. 333 (2005) 328-335
12. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., and Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108 (2006) 3068-3071
13. Yang W.J., Yang D.D., Na S., Sandusky G.E., Zhang Q., and Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 280 (2005) 9330-9335
14. Ryther R.C., Flynt A.S., Phillips III J.A., and Patton J.G. siRNA therapeutics: big potential from small RNAs. Gene Ther. 12 (2005) 5-11
15. Oku N., Yamazaki Y., Matsuura M., Sugiyama M., Hasegawa M., and Nango M. A novel non-viral gene transfer system, polycation liposomes. Adv. Drug Deliv. Rev. 52 (2001) 209-218
16. Yamakawa S., Furuyama Y., and Oku N. Development of a simple cell invasion assay system. Biol. Pharm. Bull. 23 (2000) 1264-1266
17. Oku N., Asai T., Watanabe K., Kuromi K., Nagatsuka M., Kurohane K., Kikkawa H., Ogino K., Tanaka M., Ishikawa D., Tsukada H., Momose M., Nakayama J., and Taki T. Anti-neovascular therapy using novel peptides homing to angiogenic vessels. Oncogene 21 (2002) 2662-2669